PDGFRB and sarcoma: PDGFR and its ligands have been proved to be overexpressed in glioma, sarcoma, leukemia, epithelial cell carcinoma, and other malignant tumors and affect the malignant proliferation, vascular hyperplasia, and metastasis of tumor cells.